Related Experiment Video
Updated: May 6, 2026
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
The Use of a Handheld Ultrasound Device to Guide the Axillary Vein Access during Pacemaker and
Biagio Sassone1,2,3, Giuseppe Simeti2, Santo Virzì2
1Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Background:
Although ultrasound guidance for axillary vein (AV) access (USGAVA) has been described as a reliable technique for cardiac implantable electronic device (CIED) implantation, no data is available on the use of handheld ultrasound devices (HUD) in such a setting.
Objective:
We investigated the feasibility of using a HUD for USGAVA in patients referred to our Institution for CIED implantation.
Methods:
The procedure details of 80 consecutive patients undergoing USGAVA (Group-1) from June 2020 to June 2021 were prospectively collected and compared to those of an age and sex-matched cohort of 91 patients (Group-2) who had undergone AV access with the traditional venipuncture guided by fluoroscopic landmarks.
Results:
The two groups were comparable for the success rate of venous access (92.5% versus 93.4%, p = 0.82), complication rate (1.3% versus 0.9%, p = 1.0), and procedure time (71 32 min versus 70 29 min, p = 0.9). However, Group-2 had a longer X-ray exposure time (7.6 8.4 min versus 5.7 7.3 min, p = 0.03). In Group-1, the univariate logistic regression analysis demonstrated that the AV diameter was associated with successful USGAVA (odds ratio = 3.34, 95% confidence interval 1.47-7.59, p 0.01), with a 3-fold increase of probability of success per each 1 mm increase in the AV diameter.
Conclusions:
USGAVA using a HUD for CIED implantation is a feasible, effective, and safe technique; moreover, it saves X-ray exposure time without lengthening the implant procedure time.
